Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed recent reports from the World Health Organization about COVID-19.
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed recent new World Health Organization research on vaccine protection against COVID-19.
Transcript
A report from the World Health Organization found that people are having long-lasting protection against COVID-19 when they have been both vaccinated and infected up to 12 months after infection. How do you think that changes how COVID-19 is addressed by the primary care physician for both adults and children?
So I think that, clearly, the COVID situation has been evolving now for 3 years. And so that kind of fits our anecdotal evidence that if you had all the vaccines and the COVID infection that you seem pretty well protected. And if you get COVID again it tends to be mild. I certainly have patients who've gotten COVID, 3 times so far, and they're fully immunized and then folks who still haven't gotten it at all. So I do think, because so much of the population has had a COVID infection, that if we can maintain our COVID vaccination rates and booster rates, that if this evidence continues to bear out, I think that's really exciting, because I think that's how we get to a level of herd immunity that can make COVID eventually look more like flu. And could help kind of add credence to, you get your flu shot once a year, you get your COVID shot once a year.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Methotrexate May Lower Blood Pressure in Rheumatoid Arthritis
September 4th 2025Methotrexate significantly lowered systolic blood pressure compared with sulfasalazine in adults with newly diagnosed rheumatoid arthritis, suggesting potential cardiovascular benefits beyond its anti-inflammatory effects.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Prevention, Early Intervention Highlighted in Updated High Blood Pressure Guidelines
September 4th 2025A new joint guideline from the American Heart Association and the American College of Cardiology emphasizes early treatment, close perinatal blood pressure monitoring, and incorporating the PREVENT risk calculator to personalize care.
Read More